ARCHIVES

Groups Point to NCI Restrictions As Source Of Problems, Discuss Prioritizing Trials

This article is from The Cancer Letter archive.

Vol. 29 No. 28 | July 11, 2003

Download PDF Visit The Full Archive

Related Articles

Boyd Steps Down As DTP Director, Returns to Research

February 16, 1990

NIH, NCI Get Higher Funding In 2014 Budget

January 17, 2014

Analysis Reveals Patient Subset With Lower PFS in Phase III Trial

December 30, 2011

2018 State of Cancer Care in America

February 3, 2022

Final Results from CLEOPATRA Phase III Trial Show Perjeta Increased OS 15.7 Months

September 26, 2014

In Brief: Richard Fisher Named Physician-in-Chief, Executive Vice President at Fox Chase Cancer Center

December 7, 2012